King Keytru­da: Mer­ck­'s PD-1 star scores #1 po­si­tion and $22B+ pre­dic­tion in an­oth­er top 10 block­buster list for 2025

Pre­dict­ing which of the cur­rent block­busters will as­cend to new heights is any­one’s game, and one that high­lights the cur­rent dy­nam­ics of the in­dus­try. On Fri­day it’s Glob­al­Da­ta’s turn to pick out the ther­a­pies that it be­lieves will come out on top in some in­tense­ly com­pet­i­tive spaces.

Hu­mi­ra may still top the chart for best-sell­ing drugs in the world, but Keytru­da is set to over­take the shrink­ing fran­chise in around five years time — with four oth­er drugs set to get ahead of Ab­b­Vie’s biggest cash cow.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER